Skip to content

Episealer® Knee

The only individualised implant for focal cartilage lesions in the knee

Learn more

Episealer® Talus

Personalised implant for osteochondral lesions in the ankle

Learn more

Episealer® Patellofemoral System

For patients with osteoarthritis of the patellofemoral joint

Learn more

The Episurf Process

To ensure you receive the best possible treatment for your cartilage lesion, every step in the process focuses on you.

MRI Scan
To obtain a clear image of the lesion and your knee, 2D and 3D MRI scans are taken
Damage Marking Report
These images are then used to create a virtual 3D model and visualisation of your knee joint
Episealer
This 3D model is the basis for the design of your individualised Episealer implant

Episealer Products

Patient testimonials

Press releases and financial reports

Episurf Medical enters into a letter of intent regarding the acquisition of a property portfolio with an agreed property value of approximately SEK 505 mn

Episurf Medical AB (publ) (“Episurf” or the “Company”) has today entered into a letter of intent regarding the acquisition of all shares in five property-owning companies. The agreed underlying property value amounts to approximately SEK 505 mn before deduction for deferred tax. The parties’ objective is to enter into a final share purchase agreement no later than 30 September 2026, with completion planned for around 1 November 2026. The portfolio consists of five modern, newly…

Episurf Medical has entered into an agreement for the financing of the Lilium and Setune acquisitions and closing of the property acquisitions takes place on 31 August 2026

Episurf Medical AB (publ) ("Episurf" or the "Company") (Nasdaq Stockholm: EPIS B) has entered into an agreement for the financing of the previously communicated acquisitions of the property portfolio comprising 45 properties from Fastighetsaktiebolaget Lilium (the "Lilium Acquisition") and the property portfolio comprising four properties from Setune Assets AB (the "Setune Acquisition", and together with the Lilium Acquisition, the "Acquisitions"). The closing of the Acquisitions will take place on 31 August 2026. "We are pleased…

Change in number of shares and votes in Episurf Medical

As a result of, in accordance with previously announced information, the directed issue of 2,888,888,888 Class B shares resolved on 3 July 2026 as well as the directed issue of an additional number of 868,702,560 Class B shares resolved on 8 July 2026, the number of shares and votes in Episurf Medical AB (publ) (“Episurf”) has changed. Through the above-mentioned changes, the total number of shares in Episurf as of 31 July 2026 amounts to…